Invention Grant
US08334297B2 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
有权
2,4-嘧啶二胺化合物，用于治疗炎症性疾病
- Patent Title: 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
- Patent Title (中): 2,4-嘧啶二胺化合物，用于治疗炎症性疾病
-
Application No.: US12687053Application Date: 2010-01-13
-
Publication No.: US08334297B2Publication Date: 2012-12-18
- Inventor: Hui Li , Esteban Masuda , Stephanie Yung , Taisei Kinoshita , Rongxian Ding , Rajinder Singh , Tarikere Gururaja , Donald G. Payan , Kin Tso
- Applicant: Hui Li , Esteban Masuda , Stephanie Yung , Taisei Kinoshita , Rongxian Ding , Rajinder Singh , Tarikere Gururaja , Donald G. Payan , Kin Tso
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals Inc.
- Current Assignee: Rigel Pharmaceuticals Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bozicevic, Field & Francis LLP
- Agent Rudy J. Ng; Carol L. Francis
- Main IPC: A01N43/54
- IPC: A01N43/54 ; A61K31/505
Abstract:
2,4-Pyrimidinediamine compounds represented by formula (I), methods for preparing the same and methods for treating an inflammatory disorder and for inhibiting the production of IL-23 and/or stimulating the production of IL-10 using the same:
Public/Granted literature
- US20100179164A1 2,4-PYRIMIDINEDIAMINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY DISORDERS Public/Granted day:2010-07-15
Information query
IPC分类:
